Mettler-Toledo International Inc.
Market Cap
$26.15B
P/E Ratio
37.26
EPS
$34.05
Dividend Yield
0.00%
52-Week Range
$932.72 — $1581.62
Volume
297
Avg Volume
64
Beta
1.44
Get alerted when 0K10.L hits your target price.
Free — enter your email to get started
P/E (TTM)
37.26
Forward P/E
27.29
PEG Ratio
6.28
P/S (TTM)
6.79
P/B (TTM)
-1160.51
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-4.87%
ROA (TTM)
0.23%
ROIC
—
Gross Margin
0.58%
Operating Margin
0.28%
Net Margin
—
Debt/Equity
-99.14
Current Ratio
1.14
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.03%
EPS Growth (5Y)
+0.12%
Sales Growth (3Y)
+0.01%
Sales Growth (5Y)
+0.06%
EPS Est (This Year)
$46.49
EPS Est (Next Year)
$51.04
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$3.28
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
20.61M
Float
20.21M
Free Float %
98.08%
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
US
Exchange
LSE
IPO Date
2018-01-29
Employees
16000
CEO
Patrick K. Kaltenbach
Index Membership
—
Website
https://www.mt.com
Mettler-Toledo International Inc. (0K10.L) is a healthcare company in the medical - pharmaceuticals industry listed on the LSE. With a market capitalization of $26.15B, a P/E ratio of 37.26, 0K10.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0K10.L against other stocks using dozens of fundamental and technical filters.
0QZU.L
Vertex Pharmaceuticals Incorporated
$428.00
+1.25%
$110.00B
0R2M.L
Regeneron Pharmaceuticals, Inc.
$685.53
+1.37%
$74.06B
0M3Q.L
Zoetis Inc.
$115.60
+1.72%
$55.54B
0J2O.L
Halozyme Therapeutics, Inc.
$64.11
+1.60%
$7.57B
0HD2.L
Alnylam Pharmaceuticals, Inc.
$319.08
+7.54%
$42.32B
0RD1.L
Camurus AB (publ)
$530.55
+0.06%
$31.64B
Mettler-Toledo International Inc. (0K10.L) has a trailing twelve-month (TTM) P/E ratio of 37.26. This is above the market average, which may reflect high growth expectations or premium valuation. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Mettler-Toledo International Inc. (0K10.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Mettler-Toledo International Inc. (0K10.L) has a market capitalization of $26.15 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.